loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
�we have waited a long time and we cannot possibly wait any longer.�
.[email protected]
.: "fremanezumab for the preventive treatment of chronic migraine."
.